Ambroxol Hexal Syrup 250 ml | Buy Online at Farmaclick

What is Ambroxol Hexal Syrup

ACTIVE INGREDIENTS:

Ambroxol hydrochloride.

EXCIPIENTS:

Nebulizer solution: methyl parahydroxybenzoate; propyl parahydroxybenzoate; sodium metabisulfite; citric acid monohydrate; sodium hydroxide; purified water.
Syrup: benzoic acid; sodium metabisulfite; citric acid monohydrate; sodium hydroxide; povidone; sorbitol, 70% solution; glycerol 85%; sodium cyclamate; raspberry flavoring; purified water.

INDICATIONS:

Treatment of secretory disorders in acute and chronic bronchopulmonary diseases.

CONTRAINDICATIONS/SIDE EFFECTS:

Hypersensitivity to the active ingredient or to any of the excipients; severe hepatic and/or renal impairment.

DOSAGE

>>Nebulizer solution.
Adults and children over 5 years of age: 2-3 ml of solution 1-2 times daily.
Children under 5 years of age: 2 ml of solution 1-2 times daily.
Since coughing may occur during deep breathing of aerosol, one should try to breathe normally during inhalation.
It is recommended to warm the solution to body temperature before inhalation.
In patients suffering from bronchial asthma, it is recommended to administer the usual bronchodilator before inhalation.
>>Syrup.
Adults: 10 ml (30 mg) 3 times daily.
Children up to 2 years: 2.5 ml (7.5 mg) 2 times daily.
Children from 2 to 5 years: 2.5 ml (7.5 mg) 3 times daily.
Children over 5 years: 5 ml (15 mg) 3 times daily.
It is recommended to take the syrup after meals.
Do not use ambroxol for prolonged treatments.

STORAGE:

Nebulizer solution: store at a temperature not exceeding 25°C.
Syrup: no special storage precautions.

WARNINGS:

The nebulizer solution and the syrup contain sodium metabisulfite; in sensitive subjects, especially those with a history of asthma or allergy, it may cause allergic-type reactions including symptoms of anaphylaxis and bronchospasm.
The syrup medication also contains sorbitol: unsuitable for hereditary fructose intolerance.
It may cause gastric upset and diarrhea.
Glycerol: dangerous in high doses.
It may cause headache, gastric upset, and diarrhea.
Benzoic acid: mild irritant to skin, eyes, and mucous membranes.
It may increase the risk of jaundice in newborns.
The nebulizer solution also contains methyl parahydroxybenzoate and propyl parahydroxybenzoate: they may cause allergic reactions (even delayed ones) and, exceptionally, bronchospasm.
Ambroxol must be administered with caution in patients suffering from peptic ulcer.

INTERACTIONS:

The medication generally does not interfere with other drugs.

SIDE EFFECTS:

The following side effects have been observed following the use of the product.
General symptoms.
Uncommon (>= 0.1% - <1%): hypersensitivity reactions (rash, dyspnea, pruritus), angioedema (rapid-onset swelling which may particularly affect the face and throat), fever.
Very rare (< 0.01%): anaphylactic reactions, including anaphylactic shock.
Gastrointestinal tract.
Common (>=1% - <10%): diarrhea; uncommon (>=0.1% - <1%): nausea, abdominal pain, vomiting.
Skin.
Very rare (< 0.01%): severe skin reactions, such as epidermal necrolysis and Stevens-Johnson syndrome; rarely: fatigue, dry mouth, rhinorrhea, dysuria, headache, gastrointestinal disorders (heartburn, dyspepsia, constipation, nausea, and vomiting), contact dermatitis, or other allergic reactions (especially skin rashes).

PREGNANCY AND BREASTFEEDING:

There are no clinical data available for ambroxol regarding exposed pregnancies.
Animal studies do not indicate direct or indirect harmful effects on pregnancy, embryonic/fetal development, parturition, or post-natal development.
Although preclinical studies and vast clinical experience have not shown any harmful effects after the 28th week of gestation, it is advisable to follow normal precautions regarding the intake of medications during pregnancy.
Especially during the first trimester, the intake of ambroxol is not recommended.
The drug is excreted in breast milk; therefore, the use of ambroxol is not recommended during breastfeeding.